Post by Berkeley SkyDeck

🧬 Tuesday night’s Batch 22 Bio+Health Track Dinner was a phenomenal showcase of next-generation biotech innovation! We gathered an incredible group of investors, visionary Berkeley researchers, and founders all dedicated to pushing the boundaries of what's possible in medicine and biotechnology. ✨ Four SkyDeck startups pitched their transformative technologies redefining the landscape of healthcare and medicine: • Lucina Biotherapeutics - Developing lipid-based interventions to treat macular degeneration. • Optagon Labs - Building the AI-Native R&D and production layer for manufacturers to develop, simulate, and design superior products and launch fast. • Genexgen - Developing epigenetic therapies to modulate undruggable immune pathways, enabling the first targeted treatment for hemophagocytic lymphohistiocytosis. • NeuroAge Therapeutics - AI-powered diagnostic and longevity platform using biomarkers to measure brain health and dementia risk, and provide personalized prevention protocols. 🙌 Thank you to our sponsor WilmerHale for supporting this event, to the founders pushing the boundaries of what’s possible, and to our entire community for showing up and fueling Berkeley’s biotech innovation! #Biotech #HealthTech #LifeSciences #BerkeleyInnovation #BerkeleySkyDeck #SkyDeck #HealthcareInnovation Christin Glorioso, MD PHD, Christopher Chavez, PhD, Khalil Kaddoura, Amir R Kiani, PhD, Kelly Lindberg